Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

NCT01790828 · clinicaltrials.gov ↗

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Xyntha : coagulation factor IIIV (recombinant)

Sponsor

Pfizer